← FDA Drug Approvals (Drugs@FDA)
BORTEZOMIB
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CAPLIN ONE LABS · Approved 2022-07-26
Drug application
- FDA Application #
ANDA203654- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BORTEZOMIB
- Generic name
- Bortezomib
- Active ingredients
- BORTEZOMIB
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing status
- Discontinued
- Sponsor
- CAPLIN ONE LABS
- First approval
- 2022-07-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown